SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS is drawing attention after a steep selloff amid no confirmed company update; traders debate whether broad biotech weakness and options-related trading drove the drop or whether the companys prolonged silence is adding pressure. The central catalyst remains the blinded Phase 3 REGAL trial, last reported at 78 of 80 required events: bulls see the slow event pace as a possible sign of longer survival, while bears question the delay, trial design, and prospects for a successful readout.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is caught in a sharp semiconductor selloff as traders question the sustainability of AI-infrastructure spending and cite inflation, interest-rate, and broader market concerns. The community is split between calling the decline an overdone dip and buying ahead of earningssome pointing to potential foundry customer winsand warning that the AI trade and Intels valuation may face further pressure.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

After Fridays selloff, traders are focused on a sharp futures rebound that undercut widespread Black Monday crash fears, with some crediting Russia-Ukraine peace and diesel headlines while others suspect a low-volume bounce or short-covering rally. The debate remains split between dip-buyers expecting a recovery and bears warning that volatility and further losses may follow.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Attention centers on Iovances ESMO data for lifileucel plus pembrolizumab in first-line melanoma, with traders highlighting durable responses and the reported progression-free survival while debating the limits of a small, single-arm cohort and whether the results move beyond earlier data. Sarcoma findings add a potential expansion story, but traders note that larger trials must confirm the signals; many attribute the recent share weakness to a broader biotech selloff rather than a company-specific setback.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is drawing attention after a sharp tech- and AI-linked selloff sparked crash fears, followed by a strong futures rebound that traders debate as either a short-covering bounce or a possible recovery. Concerns about AI spending and debt, along with upcoming megacap earnings, are keeping views divided on whether the selling has run its course.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp semiconductor selloff, amplified by its 3x daily leverage, amid concerns about AI spending and debt, Chinese competition, and persistent inflation. Traders are split between buying the steep dip and expecting a rebound, and warning that selling and forced liquidations may continue.

Delta Air Lines, Inc. engages in the provision of scheduled air transportation for passengers and cargo. It operates through the Airline and Refinery segments. The Airline segment provides scheduled air transportation for passengers and cargo. The Refinery segment provides jet fuel to the airline segment. The company was founded by Collett Everman Woolman in 1928 and is headquartered in Atlanta, GA.

Delta Air Lines, Inc.

Deltas quarterly earnings miss and reduced full-year outlook, driven by sharply higher fuel costs, are the main focus. Traders are split over whether strong travel and premium demand can offset margin pressure, with bulls pointing to pricing power and possible fuel relief while bears worry about further earnings weakness.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

A broad selloff in AI and neocloud stocks, fueled by worries about financing costs, debt-funded data-center expansion, and the sectors business model, has dragged NBIS lower alongside peers. Traders are split between viewing the decline as an overdone dipciting Nebiuss comparatively stronger finances and AI demandand warning that the sector could face further valuation pressure.

KraneShares Trust - KraneShares CSI China Internet ETF

KraneShares CSI China Internet ETF

Persistent weakness in Chinese internet stocks is dominating discussion, with traders citing poor China-market sentiment, regulatory and geopolitical risks, and continued underperformance versus U.S. tech. Some see oversold levels and options buying as signs of a possible rebound, while others view rallies as short-lived and the ETF as a value trap.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

A sharp AI-sector selloff and concerns about Super Micros governance and export-control risks are driving attention as the stock posts steep losses. Bulls call the decline an oversold buying opportunity and point to expected earnings and AI demand, while bears worry about compliance issues, management credibility, and a possible slowdown in AI spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Calidi Biotherapeutics, Inc. (CLDI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

This account has been verified as an official CLDI representative.

Verified Account

CalidiOfficial

Calidi Biotherapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which engages in stem cell-based platforms to revolutionize oncolytic virotherapies. The company was founded in 2014 and is headquartered in San Diego, CA.

Calidi Biotherapeutics Inc

Neutral Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

Calidi Biotherapeutics Inc - Ordinary Shares - Class A

$CLDI massive potential for squeeze this setup looks like $MSS $FBGL off the bottom we banked hard on!!

FinanceLegacy

$CLDI seriously, run away from this POS unless you plan to short.  Absolutely no future scam bio stock

$CLDI shorting is the only play here, dilution machine, operating at huge losses monthly even after they lost their offices.  CEO got last company delisted which will happen here as well.

$CLDI it’s so cute seeing all these new people pop in here thinking this is a legitimate stock with a chance 😂😂😂

Feed

News

Sentiment

Fundamentals

Info

CLDI Calidi Biotherapeutics Inc - Ordinary Shares - Class A

Fundamentals

Latest CLDI News